Skip to main content

Table S8 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer

Publication ,  Other
Stanland, LJ; Ang, HX; Hoj, JP; Chu, Y; Tan, P; Wood, KC; Luftig, MA
September 16, 2024

<p>Antibody dilutions for primary and secondary antibodies used</p>

Duke Scholars

DOI

Publication Date

September 16, 2024
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stanland, L. J., Ang, H. X., Hoj, J. P., Chu, Y., Tan, P., Wood, K. C., & Luftig, M. A. (2024). Table S8 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer. https://doi.org/10.1158/1541-7786.27035467
Stanland, Lyla J., Hazel X. Ang, Jacob P. Hoj, Yunqiang Chu, Patrick Tan, Kris C. Wood, and Micah A. Luftig. “Table S8 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer,” September 16, 2024. https://doi.org/10.1158/1541-7786.27035467.
Stanland, Lyla J., et al. Table S8 from CBF-beta mitigates PI3K-alpha-specific inhibitor killing through PIM1 in PIK3CA mutant gastric cancer. 16 Sept. 2024. Crossref, doi:10.1158/1541-7786.27035467.

DOI

Publication Date

September 16, 2024